IBSA Introduces Two New Dietary Supplements Into the U.S. Market
07 May 2024 //
BUSINESSWIRE
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
Attralus Receives FDA and EMA Orphan Designation for AT-01
19 Dec 2022 //
GLOBENEWSWIRE
Attralus Announces New Clinical Data in ATTR CM and AL With AT-01
12 Sep 2022 //
GLOBENEWSWIRE
Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product
23 Dec 2021 //
BUSINESSWIRE
Novo Integrated Sciences Granted NPN for IoNovo Iodine Branded Product
23 Dec 2021 //
BUSINESSWIRE
Medolife Announces Successful Stability Results on Escozine Conjugated
01 Jul 2021 //
GLOBENEWSWIRE
Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results
09 Dec 2019 //
PR NEWSWIRE
Cancer drug plant likely source of radio isotope detected across Europe
23 Feb 2017 //
IN PHARMATECHNOLOGIST
Vitalah® Announces Three Changes to Adult Oxylent® Formula
03 Nov 2016 //
PR NEWSWIRE
Health Canada Approves BioPharmX Corporation Study of Violet® Iodine
04 Apr 2016 //
PR NEWSWIRE
FDA Issues Declaratory Order Revoking GRAS Status of PHOs
17 Jun 2015 //
FDA LAW BLOG
UPM Pharmaceuticals to Manufacture BioPharmX`s First Commercially Available Product
10 Dec 2014 //
PRNEWSWIRE